Search clinical trials for: Coronavirus Disease 2019

Total 384951 results

Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults

Covid19 Vaccine

Paraguay
Medigen Vaccine Biologics Corp.

Completed

A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study

Covid19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19)

Covid19 Vaccine

Taiwan, Vietnam
AstraZeneca
Iqvia Pty Ltd

Completed

Study of AZD1222 for the Prevention of COVID-19 in Japan

COVID-19

Japan
AstraZeneca
Iqvia Pty Ltd

Completed

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

COVID-19 | SARS-CoV-2

United States, Chile, Peru
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above

COVID-19 Vaccine

Thailand
University of Oxford

Active, not recruiting

A Study of a Candidate COVID-19 Vaccine (COV001)

Coronavirus

United Kingdom
AstraZeneca

Terminated

A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults (VICTORIA)

COVID-19, SARS-CoV-2

Thailand, Ukraine
AstraZeneca

Completed

Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults (AZD2816)

COVID-19 | SARS-CoV-2

United Kingdom, Brazil, South Africa, Poland
PT Bio Farma
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine

Covid19

Indonesia
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents

Covid19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19

COVID-19

Taiwan
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Treat COVID-19 Patients at Home. (COVER)

COVID 19

Italy
Eli Lilly and Company

Terminated

A Study of LY3127804 in Participants With COVID-19

COVID-19 | Pneumonia

United States
EicOsis Human Health Inc.

Unknown

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

COVID-19

United States
Hospital San Carlos, Madrid

Completed

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency (COVIT-D)

Coronavirus Disease 2019 (COVID-19)

Spain
Jieming QU

Completed

Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus

2019-nCoV

China
Ataturk University

Completed

Topical Lidocaine Anesthesia for Nasopharyngeal Sampling

Local Anesthesia | Nasopharyngeal Sampling

Turkey
Mathematica Policy Research, Inc.
Department of Health and Human Services; Children's Bureau - Administration... and other collaborators

Unknown

Head Start Family and Child Experiences Survey (FACES 2019) (FACES 2019)

Head Start Participation

United States
Qilu Hospital of Shandong University

Unknown

2019-nCoV Outbreak and Cardiovascular Diseases

Cardiovascular Death; Major Adverse Cardiovascular Events

China
Mebo Research, Inc.
Aurametrix

Active, not recruiting

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

COVID-19 Vaccines

United States, Georgia, Kenya, United Kingdom
Queen Mary University of London

Active, not recruiting

Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19)

Cardiovascular Diseases | Endothelial Dysfunction

United Kingdom
Theravance Biopharma

Completed

TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation

Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)

United States
Affiliated Hospital to Academy of Military Medical...
Beijing 302 Hospital

Unknown

A New Screening Strategy for 2019 Novel Coronavirus Infection

Novel Coronavirus Infection Pneumonia

China
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
R-Pharm

Completed

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

COVID-19

Russian Federation
Acerta Pharma BV
AstraZeneca

Terminated

Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19

COVID-19

Brazil
AstraZeneca
Acerta Pharma BV

Completed

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI)

COVID-19

Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
AstraZeneca
Acerta Pharma BV

Completed

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI US)

COVID-19

United States
Kent State University

Unknown

A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic

Psychological Stress

United States
Bnai Zion Medical Center

Completed

The Impact of nCoV-2019 on Children With Migraine

Migraine Disorders | COVID-19 Pandemic

Israel
University of Alabama at Birmingham

Terminated

TXA and Corona Virus 2019 (COVID19) in Outpatients (TCOutpatient)

COVID-19

United States
Puren Hospital Affiliated to Wuhan University of...
Wuhan Hamilton Bio-technology Co., Ltd

Withdrawn

Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus

COVID-19

China
Wuhan BravoVax Co., Ltd.
National University Hospital, Singapore; Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine

COVID-19

Singapore
First Affiliated Hospital of Zhejiang University

Not yet recruiting

Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia.

COVID-19 Pneumonia

China
Institute of Biotechnology, Academy of Military...
Zhongnan Hospital

Completed

A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults

COVID-19

China
Viriom

Completed

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Covid19 | HIV-1-infection

Russian Federation
Monika Joshi

Completed

Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients

Malignancies Multiple

United States
Cairo University

Unknown

Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome

Covid19 | Chronic Inflammation | Non-Communicable Chronic Diseases

Egypt
Second Affiliated Hospital of Xi'an Jiaotong University

Withdrawn

Humanistic Care in Healthcare Workers in Coronavirus Disease 2019

Coronavirus Disease 2019
The Second Hospital of Nanjing Medical University

Withdrawn

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

COVID-19 Complicated With Refractory Intestinal Infections

China
Hospital Sírio-Libanês
Hospital Israelita Albert Einstein; Ache Laboratorios Farmaceuticos S.A.; Hospital... and other collaborators

Terminated

COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III (CoDEX)

Coronavirus Infection | Pneumonia, Viral | Acute Respiratory Distress Syndrome

Brazil
Medical University of Lodz
GlaxoSmithKline

Not yet recruiting

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

Asthma; Eosinophilic

Poland
King Hussein Cancer Center
ACDIMA Biocenter; Sana Pharmaceutical Industry; Amman Pharmaceutical Industries...

Withdrawn

The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients

2019 Novel Coronavirus

Jordan
Sinopharm Wuhan Plasma-derived Biotherapies Co....
China National Biotec Group Company Limited; Beijing Tiantan Biological Products...

Not yet recruiting

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

COVID-19

United Arab Emirates
National University of Ireland, Maynooth
Irish Research Council; Dublin City University

Completed

Dynamic Difficulty Adjustment in a P300 Speller Task for Attention Training

Attention

Ireland
Huahui Health

Recruiting

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

COVID-19

China
Abant Izzet Baysal University

Completed

Covid-19 Pandemic and Pediatric Dentistry

COVID-19 Pandemic

Turkey
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Terminated

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

2019-nCoV

China

Search clinical trials for: Coronavirus Disease 2019

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations